Analysts expect MoonLake Immunotherapeutics to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 166,242.62 | 187,155.12 | 2.17 M | 3.00 M | 27.24 M | 30.81 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 153,253.82 | 163,248.16 | 1.85 M | 2.48 M | 24.58 M | 26.51 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 159,748.22 | 175,201.64 | 2.01 M | 2.74 M | 25.91 M | 28.66 M |
Analysts expect MoonLake Immunotherapeutics to report earnings per share of -0.75 for Q3 26, against a range of -0.80 to -0.70. The most recent reported quarter, Q2 26, came in at -0.84, a 2.3% beat against the -0.86 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.56 | -0.72 | -0.63 | -0.87 | -1.10 | -0.92 | -0.98 | -0.84 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.44 | -0.55 | -0.67 | -0.68 | -0.86 | -0.90 | -0.85 | -0.78 | -0.70 | -0.81 | -0.88 | -0.78 | -0.77 | -0.76 | -0.61 | -0.61 | ||||||||||
| Low Estimate | -0.48 | -0.67 | -0.73 | -0.76 | -1.00 | -1.08 | -1.03 | -0.94 | -0.80 | -0.95 | -1.00 | -0.84 | -0.87 | -0.86 | -0.71 | -0.73 | ||||||||||
| Consensus Estimate | -0.46 | -0.61 | -0.70 | -0.72 | -0.93 | -0.99 | -0.94 | -0.86 | -0.75 | -0.88 | -0.94 | -0.81 | -0.82 | -0.81 | -0.66 | -0.67 |
Pull Wall Street consensus for MoonLake Immunotherapeutics (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=MLTX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "MLTX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=MLTX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();